EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

COVID-19 Hijacking of the Host Epigenome: Mechanisms, Biomarkers and Long-Term Consequences

Alena D Zolotarenko iD, Hakob M Poghosyan, Victoria V Sheptiy, Sergey A Bruskin iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262110372 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Alena D Zolotarenko und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Functional Genomics, Vavilov Institute of General Genetics, Russian Academy of Sciences, 119991 Moscow, Russia. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Epigenesis, Genetic, Epigenome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The epigenetics of COVID-19 is a rapidly expanding field that reveals how the SARS-CoV-2 virus initiates alterations in the host’s genome, influencing the susceptibility to infection, the disease severity, and long-term consequences, known as “long COVID.” In this review, we describe the mechanisms utilized by the virus to manipulate the host epigenome, suppressing antiviral responses and creating a favorable environment for viral replication. We also highlight virus-induced epigenetic changes across diverse cell populations that contribute to COVID-19 pathogenesis. Notably, the virus reprograms hematopoietic stem and progenitor cells, leading to long-lasting alterations in innate immunity, a phenomenon known as “trained immunity.” These epigenetic modifications are maintained in differentiated daughter cells and may explain the persistent inflammation and other symptoms of long COVID. Furthermore, we discuss emerging epigenetic biomarkers of disease severity, including methylation signatures in genes such as AIM2, HLA-C, and PARP9, as well as dysregulated miRNA profiles. Understanding this complex interplay between the virus and the host’s epigenetic landscape is crucial for developing new therapeutic approaches that target specific epigenetic modifications to suppress pathological processes and improve clinical outcomes for COVID-19 patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Epigenesis, GeneticEpigenomeHost-Pathogen InteractionsHumansBiomarkersImmunity, InnateMicroRNAsDNA Methylation

Stichwörter der Autor:innen

COVID-19epigeneticsepimarkers of disease severitylong COVIDtrained immunityviral hijacking

Substanzen

BiomarkersMicroRNAs

Autor:innen und Institutionen

  • Laboratory of Functional Genomics, Vavilov Institute of General Genetics, Russian Academy of Sciences, 119991 Moscow, Russia.

ORCID-Profile: Alena D Zolotarenko, Sergey A Bruskin

Förderung

  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Zolotarenko, A. D., Poghosyan, H. M., Sheptiy, V. V., & Bruskin, S. A. (2025). COVID-19 Hijacking of the Host Epigenome: Mechanisms, Biomarkers and Long-Term Consequences. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110372

Vancouver

Zolotarenko AD, Poghosyan HM, Sheptiy VV, Bruskin SA. COVID-19 Hijacking of the Host Epigenome: Mechanisms, Biomarkers and Long-Term Consequences. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110372

BibTeX
@article{Zolotarenko2025,
  author = {Zolotarenko, Alena D and Poghosyan, Hakob M and Sheptiy, Victoria V and Bruskin, Sergey A},
  title = {COVID-19 Hijacking of the Host Epigenome: Mechanisms, Biomarkers and Long-Term Consequences},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262110372}
}
Kostenlos starten →